Finnegan attorney Chiaki Kobayashi authored an article titled, “Genus Claiming (Including Means Plus Function “MPF” Claiming) in Biotech and Pharma: Doctrinal Trajectory and Drafting Strategies” for the June 2026 issue of LES Japan News, a journal of Licensing Executive Society Japan. Finnegan partner John D. Livingstone edited the article. The link to the full article (Japanese only) can be found here. (Vol. 67, No. 2, June 2026, pp. 32-50).
Originally printed in LES Japan News, a journal of Licensing Executive Society Japan, in its June 2026 issue. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm’s clients.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
